Shenzhen Pinnuo Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Pinnuo Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FEGMIEC. The owner is based in Shenzhen.

Room 301, Building C, No. 284, Huanguan Middle Road

Songxuan Community, Guanhu Street, Longhua District

Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FEGMIEC
FEGMIEC
Registered 2025

Trademark Classifications

Shenzhen Pinnuo Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen Pinnuo Biotechnology Co., Ltd. have?

Shenzhen Pinnuo Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Pinnuo Biotechnology Co., Ltd. file in?

Shenzhen Pinnuo Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen Pinnuo Biotechnology Co., Ltd.'s most well-known trademarks?

Shenzhen Pinnuo Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FEGMIEC. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Pinnuo Biotechnology Co., Ltd.'s trademark registration success rate?

Shenzhen Pinnuo Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.